News 2024-12-19
Porton Newsletter | Q4 2024 Recap
Porton Expands GMP Manufacturing and New Modality Services in Shanghai Fengxian
Porton Successfully Hosts Ceremony for New Modality Capacity UpgradeDrug Modalities: Innovative Services & Solutions from Porton Pharma
Click to Download
Others
More
News 2025-01-03
Porton Achieves Higher Scores in the 2024 S & P Global ESG Assessment
Porton Pharma Solutions Ltd. (hereinafter “Porton”) is glad to announce that it scored 44 (out of 100) in the 2024 S&P Global Corporate Sustainability Assessment reflecting an improvement of 6 points over the previous assessment, where scores in all the three dimensions getting improved. (CSA Score as of 27/11/2024).
News 2024-12-23
Porton Pharma Solutions and Dragon Sail Pharmaceutical Form Strategic Partnership
On December 20, 2024, Porton Pharma Solutions Ltd. (hereinafter referred to as “Porton Pharma Solutions” or “Porton”) and Dragon Sail Pharmaceutical (Shanghai) Co., Ltd. (a subsidiary of Guilin Sanjin, hereinafter referred to as “Dragon Sail Pharmaceutical”) formally signed a strategic cooperation agreement in Guilin, southern of China.
